The Journal of Neuroscience, August 20, 2003, 23(20):7470-7478
Previous Article | Next Article 
The Involvement of Glucose Metabolism in the Regulation of Inducible Nitric Oxide Synthase Gene Expression in Glial Cells: Possible Role of Glucose-6-Phosphate Dehydrogenase and CCAAT/Enhancing Binding Protein
Je-Seong Won,1,2
Yeong-Bin Im,1
Lyndon Key,1
Inderjit Singh,1 and
Avtar K. Singh2,3
Departments of 1Pediatrics and
2Pathology, Medical University of South Carolina,
Charleston, South Carolina 29425, and 3Laboratory
Medicine Service, Ralph Johnson Veterans Affairs Medical Center, Charleston,
South Carolina 29425
In rat glial cells the lipopolysaccharide (LPS)-induced inducible nitric
oxide synthase (iNOS) gene expression was enhanced by extracellular glucose
concentration in a dose-dependent manner. On the other hand,
2-deoxy-D-glucose decreased the LPS-induced iNOS gene expression
even in the presence of glucose (6 gm/l), suggesting that glucose metabolism
is linked to the regulation of iNOS gene expression. The intracellular
NADPH/NADP+ directly correlated with the extracellular glucose
concentration, and the reduction of NADPH generation via a block of
glucose-6-phosphate dehydrogenase (G6PD) by treatment with
dehydroepiandrosterone or the antisense DNA oligomer of G6PD mRNA resulted in
the inhibition of iNOS gene expression. Gel shift assays showed that
CAAT/enhancing binding protein (C/EBP), rather than AP-1 or NF-
B,
correlated better with a glucose-dependent increase in iNOS gene expression.
The induction of C/EBP DNA binding activity by LPS and glucose was
attributable mainly to the increase in C/EBP-
protein. The
cotransfection with wild-type C/EBP-
increased the iNOS promoter
activity to the level achieved with a higher glucose concentration in the
presence of LPS. Therefore, our results suggest that C/EBP-
may be a
critical mediator in glucose-mediated regulation of iNOS gene expression.
Key words: C/EBP; astrocytes; glucose; G6PD; iNOS; NADPH; NF-
B; nitric oxide
Received Aug. 12, 2002;
revised May. 27, 2003;
accepted Jun. 5, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
R. Matsui, S. Xu, K. A. Maitland, R. Mastroianni, J. A. Leopold, D. E. Handy, J. Loscalzo, and R. A. Cohen
Glucose-6-Phosphate Dehydrogenase Deficiency Decreases Vascular Superoxide and Atherosclerotic Lesions in Apolipoprotein E-/- Mice
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2006;
26(4):
910 - 916.
[Abstract]
[Full Text]
[PDF]
|
 |
|